Printer-friendly version
Corplex™ P is a human umbilical cord allograft. The allograft is dehydrated, cut into pieces, and packaged into sterile glass vials in various fill volumes.
• The extracellular matrix of Corplex™ P allografts provide protection and cushioning to the surrounding tissue
• Retains key extracellular matrix components including collagens and glycosaminoglycans, such as hyaluronic acid
• Corplex™ P absorbs 8 times its weight in water on average
Corplex™ P is a dehydrated, human umbilical cord allograft intended for homologous use.
Do not use Corplex™ P if there is evidence of active, latent infection or gangrene. Do not use Corplex™ P on compromised patients where the patient's condition may create an unacceptable risk of post-operative infection or complications.
Corplex™ P product is for single patient use only. Do not use portions of an allograft from one sterile package on multiple patients. Do not resterilize. Do not place Corplex™ P in a procedure pack or tray that is to be sterilized prior to use.
No current Adverse Effects or Reactions attributed to the Corplex™ P allograft.
The Corplex™ P allograft should be maintained in its original packaging and stored at ambient temperature (0°C-38°C) until ready for use. When stored properly in their original packaging, Corplex™ P allografts are shelf-stable for up to three years.
| Assigned HCPCS code | ● |
| Cryopreserved | |
| Dehydrated | ● |
| Desiccated | |
| Flowable | |
| Micronized | |
| Minimally manipulated | |
| Sheet form | |
| Requires refrigeration | |
| Shelf life greater than 2 years | ● |
| Shelf life limited | ● |
| Indicated for acute wounds | |
| Indicated for chronic wounds | |
| Indicated for diabetic ulcers | |
| Indicated for pressure ulcers | |
| Indicated for surgical wounds | |
| Indicated for third-degree burns | |
| Indicated for venous ulcers | |
| Contact manufacturer for usage guidelines | ● |
| Educational Material Available | ● |
| Free Samples/Trials Available | ● |
| Published Clinical Article Available |
Remove the clear pouch from the box. Using proper aseptic technique, peel open the clear peel pouch using the chevron opening and present the vial into the sterile field, taking care to avoid contamination of sterile field instruments with non-sterile surfaces of the outer package. Withdraw the appropriate amount of saline per the size of the Corplex™ P product to be prepared per instructions for use. Remove the foil cap and discard. Wipe around the opening with the alcohol swab. Aseptically introduce the recommended volume of 0.9% sterile saline into the vial with an appropriately sized gauge needle. Swirl the vial until saline is incorporated. Once the material has been rehydrated and the application site has been properly prepared, remove the stopper and Corplex™ P may be applied to the treatment area. The product is intended to be packed and/or filled into voids to protect and cushion. The solution should be administered immediately following reconstitution. Once the desired amount is delivered, discard any unwanted/unused material in accordance with biohazard protocols. If desired, the physician may choose to rehydrate Corplex™ P with the patient's own bodily fluids. Remove the foil and stopper from the vial. Apply a thin layer of Corplex™ P onto the treatment area.
StimLabs, LLC is a leader in regenerative technologies, with an extensive product pipeline, a portfolio of intellectual property and a suite of placental-derived products.